Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 758

Sort by

Sort Order Select

Journal Articles

The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery

Soravis Osataphan, Rushad Patell, Mrigya Babuta, Rachel P. Rosovsky, Yohei Hisada, Charly Edmiston, Pavania Elavalakanar, Michael A. Pfeffer, Amy Bregar, Amanda Ramos, Leslie Garrett, Siyang Ren, Donna Neuberg, Gyongyi Szabo, Robert Flaumenhaft, Nigel Mackman, Meghan Shea, Jeffrey I. Zwicker

Blood Adv (2025) 9 (17): 4472–4476.

https://doi.org/10.1182/bloodadvances.2025016107

Published: 2025

Includes: Supplemental data

Journal Articles

Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura

Bérangère S Joly, Adrien Joseph, Raïda Bouzid, Pierre Boisseau, Thérésa Kwon, Claire Dossier, Dr, Nathalie Biebuyck, Olivia Boyer, Vassilis Tsatsaris, Jérôme Harambat, Prof, Yahsou Delmas, Olivier Moranne, Anne-Laure Sellier-Leclerc, Manon Marie, Christelle Barbet, François Provôt, Ygal Benhamou, Agnès Veyradier, Pr, Paul Coppo

Blood Adv bloodadvances.2025017638.

https://doi.org/10.1182/bloodadvances.2025017638

Published: 2025

Includes: Supplemental data

Journal Articles

Addition of ADAMTS13 Testing to Cryptogenic Stroke Evaluation: Index Case and Single-Center Screening Initial Experience

Aaron B Boothby, Jorge Nicolas Ruiz Lopez, Livia Hegerova, Dharmini Manogna, Rangaswamy Chintapatla, Samantha Harris, Gayle Teramura, David L Tirschwell, Breana Taylor, Sioban B. Keel

Blood Adv bloodadvances.2025017702.

https://doi.org/10.1182/bloodadvances.2025017702

Published: 2025

Journal Articles

Racial disparities in the management of deep vein thrombosis from a nationwide hospitalization study

Jayalekshmi Jayakumar, Manasa Ginjupalli, Nikhil Vojjala, Davin Turku, Fiqe Khan, Srijani Thannir, Aju Kalaivani Babu, Srinishant Rajarajan, Tijin Ann Mathew, Arya Mariam Roy

Blood Adv (2025) 9 (17): 4364–4367.

https://doi.org/10.1182/bloodadvances.2025016171

Published: 2025

Journal Articles

Platelet-activating histone/antihistone IgG complexes in anti-PF4–negative thrombosis and thrombocytopenia syndrome

Blood Adv (2025) 9 (16): 4323–4335.

https://doi.org/10.1182/bloodadvances.2024015076

Published: 2025

Includes: Supplemental data

Journal Articles

SGLT2i-associated erythrocytosis: closing the evidence gap

Benjamin Chin-Yee, Cyrus C. Hsia

Blood Adv (2025) 9 (16): 4321–4322.

https://doi.org/10.1182/bloodadvances.2025016967

Published: 2025

Journal Articles

Diagnosis of von Willebrand Disease

Mackenzie Bowman, Paula D. James

Blood Adv bloodadvances.2025016485.

https://doi.org/10.1182/bloodadvances.2025016485

Published: 2025

Journal Articles

Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism

Sirui Ma, Yu-Cheng Chang, Cho Han Chiang, Junmin Song, Yu-Che Lee, Ko-Yun Chang, Robert A Redd, Thita Chiasakul, Ellen P. McCarthy, Jeffrey I. Zwicker, Rushad Patell, Avi Leader

Blood Adv bloodadvances.2025017523.

https://doi.org/10.1182/bloodadvances.2025017523

Published: 2025

Includes: Supplemental data

Journal Articles

Arterial human blood flow can be stopped by cables of VWF and platelets without coagulation

Edouard Machenaud, John W. Weisel, Rustem I Litvinov, Chandrasekaran Nagaswami, David N Ku

Blood Adv bloodadvances.2025017354.

https://doi.org/10.1182/bloodadvances.2025017354

Published: 2025

Includes: Supplemental data

Journal Articles

Uncovering the role of the Hsp40 family member cysteine string protein-α in mouse platelets

Alexis N. Smith, Hammodah R. Alfar, Smita Joshi, Daniëlle M. Coenen, Joshua Lykins, Isabelle C. Becker, Brittany E. Dong, Harry Chanzu, Chi Peng, Kanakanagavalli Shravani Prakhya, Linda Omali, Irina D. Pokrovskaya, Brian Storrie, Joseph Italiano, Sidney W. Whiteheart

Blood Adv (2025) 9 (16): 4111–4125.

https://doi.org/10.1182/bloodadvances.2024014870

Published: 2025

Includes: Supplemental data

Journal Articles

The balancing act after pediatric venous thromboembolism

Hilary Whitworth, Leslie Raffini

Blood Adv (2025) 9 (15): 3905–3906.

https://doi.org/10.1182/bloodadvances.2025016871

Published: 2025

Journal Articles

Exorcizing the devil of factor VIII inhibitors

Paul C. Moorehead

Blood Adv (2025) 9 (15): 3716–3717.

https://doi.org/10.1182/bloodadvances.2025016643

Published: 2025

Journal Articles

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis

Samira Glaeser-Khan, Satoko Ito, Manraj Sra, Rhys Richmond, Robert D Bona, Harlan Krumholz, Stacy E Croteau, Adam Cuker, George Goshua

Blood Adv bloodadvances.2025016822.

https://doi.org/10.1182/bloodadvances.2025016822

Published: 2025

Includes: Supplemental data

Journal Articles

Phosphorylation at Y317 on Syk Negatively Regulates Both ITAM and hemITAM-Mediated Signaling and Function in Platelets

Manal Elzoheiry, Carol A Dangelmaier, Dhruv N Vajipayajula, Monica N Wright, Alexander Tsygankov, Satya P. P Kunapuli

Blood Adv bloodadvances.2025016714.

https://doi.org/10.1182/bloodadvances.2025016714

Published: 2025

Includes: Supplemental data

Journal Articles

Trp1250, Lys1252 and Arg1367 of ADAMTS13 comprise a hot-spot for anti-CUB domain antibodies in patients with iTTP.

Tim Postmus, Robin Jansen, Paul Kaijen, Floris P.J. van Alphen, Carmen van der Zwaan, Arie J Hoogendijk, Paul Coppo, Bérangère S Joly, Agnès Veyradier, Pr, Karen Vanhoorelbeke, Gerry A.F. Nicolaes, Jan Voorberg

Blood Adv bloodadvances.2025017193.

https://doi.org/10.1182/bloodadvances.2025017193

Published: 2025

Includes: Supplemental data

Journal Articles

Updating Clinical Guidelines with Limited Evidence: Case Study of ASH/ISTH Pediatric VTE Treatment Guidelines

Ali Choaib, Aseel Alkhader, Muayad Azzam, Hassan Kawtharany, Marisol Betensky, Leslie Raffini, Rachel Sara Bercovitz, Sara K Vesely, Paul Monagle, Reem A. Mustafa

Blood Adv bloodadvances.2025017398.

https://doi.org/10.1182/bloodadvances.2025017398

Published: 2025

Journal Articles

Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX

Enhao Li, Zekun Li, Jinzeng Wang, Haoyang Wu, Yilun Xue, Can Lou, Zhenping Chen, Feng Liu, Wenman Wu, Qiulan Ding, Runhui Wu, Xuefeng Wang, Jing Dai

Blood Adv (2025) 9 (15): 3967–3978.

https://doi.org/10.1182/bloodadvances.2025015799

Published: 2025

Includes: Supplemental data

Journal Articles

Inaccuracies of venous thromboembolism risk assessment and prevention practices among medically ill patients

Brandyn D. Lau, Aditya Bhave, Jennifer C. Yui, Rakhi Naik, Kathryn E. Dane, John Lindsley, Dauryne L. Shaffer, Peggy S. Kraus, Erik H. Hoyer, Elliott R. Haut, Michael B. Streiff

Blood Adv (2025) 9 (15): 3929–3936.

https://doi.org/10.1182/bloodadvances.2024015306

Published: 2025

Includes: Supplemental data

Journal Articles

The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component

Kari A. O. Tikkinen, Deborah M. Siegal, P. J. Devereaux, Sara V. Tornberg, Flavia K. Borges, Sandra Ofori, Jehonathan Pinthus, Bobby Shayegan, Lauri I. Lavikainen, Gordon H. Guyatt, Pavel S. Roshanov

Blood Adv (2025) 9 (15): 3837–3844.

https://doi.org/10.1182/bloodadvances.2024015515

Published: 2025

Journal Articles

Recurrent thrombosis and major bleeding in children treated for VTE

Stephanie F. Lenahan, Anne Blackmore, Matthew Fenchel, Evan Thomas, Joseph S. Palumbo, Cristina Tarango

Blood Adv (2025) 9 (15): 3824–3831.

https://doi.org/10.1182/bloodadvances.2025016135

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

The efficacy of rosuvastatin to reduce circulating tissue factor extracellular vesicles after ovarian cancer surgery

Optimizing ADAMTS13 prophylaxis to reduce relapse and organ failure in congenital thrombotic thrombocytopenic purpura

Addition of ADAMTS13 Testing to Cryptogenic Stroke Evaluation: Index Case and Single-Center Screening Initial Experience

Racial disparities in the management of deep vein thrombosis from a nationwide hospitalization study

Platelet-activating histone/antihistone IgG complexes in anti-PF4–negative thrombosis and thrombocytopenia syndrome

SGLT2i-associated erythrocytosis: closing the evidence gap

Diagnosis of von Willebrand Disease

Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism

Arterial human blood flow can be stopped by cables of VWF and platelets without coagulation

Uncovering the role of the Hsp40 family member cysteine string protein-α in mouse platelets

The balancing act after pediatric venous thromboembolism

Exorcizing the devil of factor VIII inhibitors

Emicizumab for preventing intracranial hemorrhage in infants with severe hemophilia A: a cost-effectiveness analysis

Phosphorylation at Y317 on Syk Negatively Regulates Both ITAM and hemITAM-Mediated Signaling and Function in Platelets

Trp1250, Lys1252 and Arg1367 of ADAMTS13 comprise a hot-spot for anti-CUB domain antibodies in patients with iTTP.

Updating Clinical Guidelines with Limited Evidence: Case Study of ASH/ISTH Pediatric VTE Treatment Guidelines

Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX

Inaccuracies of venous thromboembolism risk assessment and prevention practices among medically ill patients

The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component

Recurrent thrombosis and major bleeding in children treated for VTE

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only